# Ann H. Partridge

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ann-h-partridge/

## Facts

| Field | Value |
| --- | --- |
| Citations | 46,623 |
| Field | Breast Cancer Treatment Studies |
| h-index | 101 |
| i10-index | 383 |
| Last Known Institution | Harvard University |
| OpenAlex ID | https://openalex.org/A5039694693 |
| ORCID iD | 0000-0002-4722-4824 |
| Works | 1,041 |

## Researcher papers

Showing 12 of 15.

- [Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013](https://scholariq.org/papers/personalizing-the-treatment-of-women-with-early-breast-cancer-highlights-of-the/)
- [American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients](https://scholariq.org/papers/american-society-of-clinical-oncology-recommendations-on-fertility-preservation/)
- [Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015](https://scholariq.org/papers/tailoring-therapies-improving-the-management-of-early-breast-cancer-st-gallen/)
- [Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update](https://scholariq.org/papers/fertility-preservation-for-patients-with-cancer-american-society-of-clinical/)
- [Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update](https://scholariq.org/papers/fertility-preservation-in-patients-with-cancer-asco-clinical-practice-guideline/)
- [De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017](https://scholariq.org/papers/de-escalating-and-escalating-treatments-for-early-stage-breast-cancer-the-st/)
- [Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up](https://scholariq.org/papers/early-breast-cancer-esmo-clinical-practice-guideline-for-diagnosis-treatment-and/)
- [Cancer and fertility preservation: international recommendations from an expert meeting](https://scholariq.org/papers/cancer-and-fertility-preservation-international-recommendations-from-an-expert/)
- [Web-Based Survey of Fertility Issues in Young Women With Breast Cancer](https://scholariq.org/papers/web-based-survey-of-fertility-issues-in-young-women-with-breast-cancer/)
- [Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer](https://scholariq.org/papers/adjuvant-paclitaxel-and-trastuzumab-for-node-negative-her2-positive-breast/)
- [Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation](https://scholariq.org/papers/screening-assessment-and-care-of-anxiety-and-depressive-symptoms-in-adults-with/)
- [The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)](https://scholariq.org/papers/the-comet-comparison-of-operative-versus-monitoring-and-endocrine-therapy-trial/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Risks and Factors](https://scholariq.org/topics/cancer-risks-and-factors/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Reproductive Biology and Fertility](https://scholariq.org/topics/reproductive-biology-and-fertility/)

## Researcher university

- [Harvard University](https://scholariq.org/institutions/harvard-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
